Even more on the "New Horizons in Oral Medication For CLL Treatment"

Even more on the "New Horizons in Oral Medication For CLL Treatment"

Andrew Schorr has just posted his latest video interview and broadcast on latest developments coming out of ASH.

“Dr. Steven Rosen, from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago, expresses his excitement about advancements in blood cancer treatments presented at the 2012 American Society of Hematology annual meeting. Dr. Rosen explains one of the key factors for determining the best treatment course is understanding the genetics of each individual's cancer. As survivorship increases, the paradigm of care is shifting to focus on long term disease management and maintaining quality of life.”


Brian Koffman has also posted the second video of in his series of three that make up his interview of Dr Pagel bkoffman.blogspot.co.uk/ .


Featured Content

Multiple Myeloma Survey!

Earn $25 per survey, up to $100!

Learn More

Featured by HealthUnlocked

2 Replies

  • Hi I have found these videos bring great hope but when I saw my consultant today he was lukewarm about ASH. So we will wait and see.

  • Yes they do, I guess time will tell. Hope all went well for you today

You may also like...